Roy A. Beveridge

Sr. VP & Chief Medical Officer, Humana.

Companies

Epizyme, Inc.Board member Nov 18, 2021 to Aug 16, 2022¹
HumanaSr. VP & Chief Medical Officer Jun 17, 2013 to Apr 1, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Humana HUM10,791 shares³$4.6M at $425.56Apr 1, 2019
Epizyme, Inc.0 shares⁴Aug 12, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 12, 2022Returned to company 25,696 shares of Epizyme, Inc.⁴
Aug 12, 2022Returned to company 20,341 shares of Epizyme, Inc.⁴
Jun 30, 2022Granted 8,928 shares at $1.47 of Epizyme, Inc.⁵
May 17, 2022Granted 8,994 shares of Epizyme, Inc.⁶
Mar 31, 2022Granted 11,413 shares at $1.15 of Epizyme, Inc.⁷
Nov 16, 2021Granted 16,702 shares of Epizyme, Inc.⁸
Feb 20, 2019Gift 100 shares of Humana⁹
Feb 19, 2019Sold 8,278 shares at $307.16 of Humana⁹
Feb 19, 2019Exercised options 7,085 shares at $167.81 of Humana⁹
Feb 19, 2019Shares withheld for tax 325 shares at $307.21 of Humana⁹
Feb 19, 2019Exercised options 595 shares at $167.81 of Humana⁹
Dec 15, 2018Shares withheld for tax 163 shares at $304.05 of Humana¹⁰
Dec 15, 2018Exercised options 341 shares of Humana¹⁰
Dec 15, 2018Shares withheld for tax 401 shares at $304.05 of Humana¹⁰
Dec 15, 2018Exercised options 843 shares of Humana¹⁰
Dec 15, 2018Shares withheld for tax 520 shares at $304.05 of Humana¹⁰
Dec 15, 2018Exercised options 1,093 shares of Humana¹⁰
Nov 8, 2018Sold 4,622 shares at $341.06 of Humana¹¹
Aug 6, 2018Sold 14,306 shares at $324.25 of Humana¹²
Aug 6, 2018Exercised options 14,306 shares at $164.65 of Humana¹²
Aug 6, 2018Shares withheld for tax 310 shares at $322.73 of Humana¹²
Aug 6, 2018Exercised options 607 shares at $164.65 of Humana¹²
Aug 6, 2018Shares withheld for tax 328 shares at $322.73 of Humana¹²
Aug 6, 2018Exercised options 1,291 shares at $81.80 of Humana¹²
May 18, 2018Gift 104 shares of Humana¹³

Trade performance

Date	Stock	Trade	Value	Return since	Vs S&P since	Vs S&P, 1 year
Feb 19, 2019	HUM	Sale	$2.5M	+41.5%	+136.3%	−2.2%

Returns are price-only (no dividends), measured from the trade date.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREpizyme, Inc., Board member
2
SEC EDGARHumana, Sr. VP & Chief Medical Officer
3
SEC EDGARHumana shares after the filing of Apr 1, 2019
4
SEC EDGAREpizyme, Inc. shares after the filing of Aug 12, 2022
5
SEC EDGARForm 4 filed Jul 5, 2022
6
SEC EDGARForm 4 filed May 19, 2022
7
SEC EDGARForm 4 filed Apr 1, 2022
8
SEC EDGARForm 4 filed Nov 18, 2021
9
SEC EDGARForm 4 filed Feb 21, 2019
10
SEC EDGARForm 4 filed Dec 18, 2018
11
SEC EDGARForm 4 filed Nov 13, 2018
12
SEC EDGARForm 4 filed Aug 8, 2018
13
SEC EDGARForm 4 filed May 18, 2018